Mechanism of tumorigenesis by the HTLV-i virus
Uchiyama, T.; Umadome, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 44(10): 2248-2255
1986
ISSN/ISBN: 0047-1852 PMID: 2881011 Document Number: 274589
Document emailed within 1 workday
Related Documents
Miwa, M.; Shimotohno, K.; Hoshino, H.; Fujino, M.; Sugimura, T. 1984: Detection of pX proteins in human T-cell leukemia virus (HTLV)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-i and Xc DNA of HTLV-Ii proviruses Gan 75(9): 752-755Takeoka, H.; Furusyo, N.; Toyoda, K.; Murata, M.; Sagara, Y.; Kashiwagi, S.; Hayashi, J. 2007: Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1 American Journal of Tropical Medicine and Hygiene 77(1): 192-196
Ikeda, K.; Inaba, N.; Takamizawa, H. 1993: Vertical transmission human T-cell lymphotropic virus type-i (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-i infection Nihon Sanka Fujinka Gakkai Zasshi 45(11): 1283-1288
Mahieux, R.; Gessain, A. 2005: Les nouveaux rétrovirus humains HTLV-3 et HTLV-4 - New human retroviruses : HTLV-3 and HTLV-4 Medecine Tropicale 65(6): 525-528
Jové, J.; Barrera, J.M.; Alaban, E.; Crusat, M. 1986: Prevalence of delta virus and HTLV-IIi virus infections in the severely mentally handicapped Medicina Clinica 86(3): 133
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Kaplan, J.E.; Oleske, J.M.; Getchell, J.P.; Kalyanaraman, V.S.; Minnefor, A.B.; Zabala-Ablan, M.; Joshi, V.; Denny, T.; Cabradilla, C.D.; Rogers, M.F. 1985: Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome Pediatric Infectious Disease 4(5): 468-471
Vorechovský, I.; Undén, A.B.; Sandstedt, B.; Toftgård, R.; Ståhle-Bäckdahl, M. 1997: Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: support for a gatekeeper mechanism in skin tumorigenesis Cancer Research 57(21): 4677-4681
Zahonero, C.; Sepúlveda, J.M.; Sánchez-Gómez, P. 2015: Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target Revista de Neurologia 61(2): 85-93
Fujisawa, J.; Hirai, H.; Suzuki, T.; Yoshida, M. 1993: Mechanism of transcriptional activation by HTLV-1 Tax Human Cell 6(4): 266-272
Pellet, C.; Lebbé, C. 2000: Kaposi's disease and HHV8: a new model of virus-induced tumorigenesis Pathologie-Biologie 48(6): 529-532
Banks, R.A.; Babcock, G.F.; Whitmore, A.C.; Haughton, G. 1979: Effect of immunologic intervention on in vivo murine Rous sarcoma virus tumorigenesis Journal of the National Cancer Institute 63(6): 1423-1431
Nicholson, J.K.; Cross, G.D.; Callaway, C.S.; McDougal, J.S. 1986: In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) Journal of Immunology 137(1): 323-329
Heidari, S.; Berke, Z.; Berglöf, A.; Woldegiorgis, A.; Smith, C.I.; Dalianis, T. 1999: Susceptibility to polyoma virus tumorigenesis in X-linked immunodeficient (XID) and B-cell deficient (microMT) mice is not increased In Vivo 13(6): 439-444
Vago, L.; Parravicini, C.L.; Antonacci, C.M.; Cristina, S.; Costanzi, G.C.; Lazzarin, A.; Moroni, M.; Berti, E.; Nonnenmacher, L.; Gluckman, J.C. 1986: Pathology of HTLV III/LAV virus infection Pathologica 78(1053): 1-24
Buisson, G.G.; Vernant, J.C. 1990: Neurologic pathology and HTLV-i virus La Revue du Praticien 40(23): 2124-2126
Levenbook, I.S.; Kolomiyets, O.L.; Nikolayeva, M.A. 1982: Ultrastructural and histochemical studies on soft tissue tumours and tumorigenesis induced by oncogenic adenoviruses and Rous sarcoma virus in hamsters Iarc Scientific Publications 34: 325-329
Merle, H.; Smadja, D.; Béra, O.; Grolier-Bois, L.; Vernant, J.C. 1993: Uveo-papillitis associated with paraparesis caused by HTLV-1 virus Presse Medicale 22(25): 1179-1182